Dr. Daniel T. Layish, MD

Dr. Layish practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Layish's NPI, 1659350320, was assigned on January 11, 2006. Dr. Layish graduated from Boston University School Of Medicine in 1990. Dr. Layish holds Florida license ME72566.

Dr. Layish's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Layish's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Layish is also affiliated with Orlando Regional Medical Center. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Layish to 1 more hospital, 5 group practices and clinics, 5 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Layish practices, 9 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Layish's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Layish is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Layish's licenses on file in 2 states: Florida and North Carolina.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), hypersomnia, lung resection, pleural effusion, pneumonia and pulmonary fibrosis among the conditions Dr. Layish treats.

CMS data shows 5,013 Medicare services from Dr. Layish across 17 procedure codes in 2024, for 1,485 Medicare patients. Medicare paid $309,413 for them.

CMS counts 1,485 Medicare patients who saw Dr. Layish in 2024. The largest group is 75 to 84, with 570 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Layish's median patient age at 72, with 56% women.

In 2024, Dr. Layish wrote 5,446 Medicare Part D claims for 652 patients. CMS names the drug for 5,065 of them, across 90 drugs with 11 or more claims each, at $21,227,771 in total drug cost. In 2023, CMS named 5,006 claims across 83 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Layish for performance year 2024, reported as part of a group. Dr. Layish accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Layish as offering telehealth.

Dmand AI links 3 papers to Dr. Layish in 2020. 2020 was the busiest year, with 2. Dr. Layish's most frequent co-authors are Cori L. Daines, MD, Rose A. Franco, MD and Benjamin Taylor Kopp, MD.

Dmand AI links Dr. Layish to 12 clinical trials, 6 of them phase 2 studies. Conditions studied include Cystic Fibrosis, Infant, Newborn, Diseases and Pulmonary Arterial Hypertension. Bristol-Myers Squibb sponsors the most, 2.

CMS Open Payments shows 1,107 general payments to Dr. Layish from 66 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Genentech, Inc. paid the most, $23,952.

Dmand AI lists 7 awards for Dr. Layish, most recently Chairman, Pulmonary Department in 2018.

Dr. Layish graduated from Boston University School Of Medicine in 1990. Dr. Layish is a member of AOA, AASM, ACCP, SCCM, ACP and ATS.

Dr. Layish is in network with 18 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.